Objective-Impaired hepatic phosphatidylcholine (PC) synthesis lowers plasma lipids. We, therefore, tested the hypothesis that lack of phosphatidylethanolamine N-methyltransferase (PEMT), a hepatic enzyme catalyzing PC biosynthesis, attenuates the development of atherosclerosis. 
A n elevated level of circulating very low-density lipoproteins (VLDLs) and low-density lipoproteins (LDLs) is a well established risk factor for development of atherosclerosis (reviewed in 1, 2 ) , and can be attributable to increased secretion or decreased clearance of VLDLs. Production of the neutral lipid core (cholesteryl esters [CE] and triacylglycerols [TG] ) of circulating lipoproteins has been studied extensively in relation to cardiovascular disease. 3 The link between phospholipids (PLs) on the surface monolayer of the lipoproteins and atherosclerosis is, however, less well understood.
In the early stages of hepatic VLDL assembly, during cotranslational translocation of apoB into the endoplasmic reticulum (ER) lumen, PLs associate with apoB; PLs may also be added to apoB at later stages of VLDL assembly. 4 -6 PLs play a fundamental role in VLDL formation and secretion. [7] [8] [9] [10] [11] [12] In plasma, the PL monolayer provides a site of contact between the lipoprotein particle and other components, such as lipases and cell surface receptors. Consequently, the PL composition of plasma lipoproteins might modulate lipoprotein metabolism.
At steady state, the major PLs of mature VLDLs in plasma are phosphatidylcholine (PC) and sphingomyelin (SM). [13] [14] [15] However, when lipolysis is blocked, the most abundant PLs on nascent VLDLs are PC and phosphatidylethanolamine (PE). 15 Moreover, compared to mature circulating VLDLs, newly-formed VLDLs isolated from the ER lumen 16, 17 or Golgi apparatus 14 are enriched in PE. PC and PE are also the major PLs of hepatic ER membranes, 18 the site at which VLDL assembly is initiated. Hepatic PC and PE are synthesized by the CDP-choline and CDP-ethanolamine pathways, respectively 19 ; PE is also synthesized in mitochondria by the decarboxylation of phosphatidylserine. 20 In the liver, some PE is converted into PC by 3 sequential methylation reactions catalyzed by the essentially liver-specific enzyme, phosphatidylethanolamine N-methyltransferase (PEMT). 21, 22 Approximately 30% of hepatic PC is made by PEMT. 23 For each PC molecule produced by PEMT, 3 molecules of S-adenosylhomocysteine (AdoHcy) are generated. AdoHcy is the precursor of homocysteine (Hcy) that is released into the circulation. Increased plasma Hcy is an independent risk factor for atherosclerosis. 24 -26 Elimination of PEMT in mice fed a high-fat/high-cholesterol (HF/HC) diet for 3 weeks reduces plasma levels of PC and cholesterol by 20% to 40%, and reduces plasma TG levels and the hepatic secretion of apoB100 by Ͼ50%. 9 We hypothesized that the hypolipidemic effect of PEMT deficiency would attenuate the development of atherosclerosis. We therefore eliminated PEMT expression in mice lacking LDL receptors (Ldlr Ϫ/Ϫ mice), a well-established model of atherosclerosis. The results provide the first demonstration that hepatic PC biosynthesis is directly involved in development of atherosclerosis in mice.
Materials and Methods
The mice used in these experiments were cross bred into the C57B16 background. At 9 to 12 weeks of age, the mice were fed a HF/HC diet (Basal Diet #TD 84172 from Harlan TEKLAD. Madison WI) containing 20% olive oil (w/w) and 1.25% cholesterol for 16 weeks. Procedures, assays and analyses of data are standard in this field of research and are presented in supplementary material.
Results

PEMT Deficiency in Ldlr ؊/؊ Mice Reduces Atherogenic Plasma Lipoproteins
After 16 weeks of the HF/HC diet, female and male Pemt ϩ/ϩ / Ldlr Ϫ/Ϫ mice that had been fasted overnight developed milky plasma. In contrast, the plasma from Pemt Ϫ/Ϫ /Ldlr Ϫ/Ϫ mice remained clear ( Figure 1A and 1B). Levels of plasma TG and CE (supplemental Table I Table I ). The amounts of choline-containing PLs, TG, and cholesterol in VLDLs/IDLs/LDLs of Pemt Ϫ/Ϫ /Ldlr Ϫ/Ϫ mice were lower than in Pemt ϩ/ϩ /Ldlr Ϫ/Ϫ mice ( Figure 1C through 1H). However, PEMT deficiency did not alter the levels of HDL-associated PLs or cholesterol ( Figure 1C through 1F) .
The amount of apoB in plasma reflects the number of VLDL/IDL/LDL particles because each particle contains a single apoB molecule. 27 Figure 2 shows that amounts of plasma apos B100 and B48 were reduced by PEMT deficiency in mice with the Ldlr Ϫ/Ϫ background. The amounts of plasma apoAI and apoE were not affected by PEMT deficiency (immunoblotting data not shown).
Elevated plasma Hcy is an established risk factor for cardiovascular disease and atherosclerosis. 24 -26 The PEMT reaction generates Ϸ50% of plasma Hcy in mice and has been predicted to consume similar amounts of AdoMet in humans. 28 
Pemt
؊/؊
/Ldlr ؊/؊ Mice Are Resistant to Development of Atherosclerotic Lesions
To determine whether hepatic PEMT deficiency reduced atherosclerosis in Ldlr Ϫ/Ϫ mice, we examined atherosclerotic lesion development in the aorta. In the aortic root area, the size of atherosclerotic plaques stained by oil red O was markedly smaller in Pemt ϩ/ϩ /Ldlr Ϫ/Ϫ mice than in Pemt ϩ/ϩ / Ldlr Ϫ/Ϫ mice after 16 weeks of the HF/HC diet ( Figure 3A ). Moreover, the extent of atherosclerotic lesions in the entire aorta (en face analysis) was Ϸ80% (PϽ0.001) smaller in both male and female Pemt Figure 3B and 3C).
VLDL Secretion Is Moderately Reduced in Pemt
We investigated potential mechanisms underlying the reduced plasma levels of atherogenic lipoproteins in mice lacking PEMT. Hepatic VLDL secretion was measured in vivo in mice fed the HF/HC diet for 4 weeks. In these mice, plasma lipid levels were reduced to the same extent as in mice fed the HF/HC diet for 16 weeks (data not shown). We assessed VLDL secretion by injection of Poloxamer 407 into the mice. 30 In the presence of Poloxamer 407, the accumulation of TG in plasma reflects newly-secreted VLDLs. Less VLDL-TG accumulated in plasma of Pemt Figure 4A ), indicating reduced VLDL secretion. The rate of TG secretion by Pemt Ϫ/Ϫ / Ldlr Ϫ/Ϫ mice over a 3-hour period was 32% (106.7Ϯ24.9 versus 157.6Ϯ36.3 mol/kg/h, PϽ0.05) lower than in Pemt -ϩ/ϩ /Ldlr Ϫ/Ϫ mice ( Figure 4B ). Thus, PEMT deficiency in Ldlr Ϫ/Ϫ mice modestly reduces TG secretion into plasma. Consistent with decreased VLDL secretion, hepatic TG was increased Ϸ2-fold (supplemental Table I ).
The amount of TG and apoB secreted by cultured hepatocytes is frequently used as a measure of hepatic VLDL secretion. 31 in plasma. When the activity of plasma lipases was blocked in Pemt Ϫ/Ϫ /Ldlr Ϫ/Ϫ mice by Poloxamer 407, plasma VLDLs contained 34% less PC than did VLDLs from Pemt ϩ/ϩ / Ldlr Ϫ/Ϫ mice (PϽ0.01) with no significant change in PE ( Figure 5A ). Consequently, the PC/PE molar ratio in nascent plasma VLDLs from Pemt Ϫ/Ϫ /Ldlr Ϫ/Ϫ mice was 34% (PϽ0.01) lower than in Pemt ϩ/ϩ /Ldlr Ϫ/Ϫ mice ( Figure 5A ). Similar results were observed in female mice (data not shown). The PC content of VLDLs secreted by primary hepatocytes from male Pemt Ϫ/Ϫ /Ldlr Ϫ/Ϫ mice was also lower (by 49%, PϽ0.05) than in Pemt ϩ/ϩ /Ldlr Ϫ/Ϫ mice ( Figure 5B) .
We next measured the PL composition of hepatic microsomal luminal contents. The PC/PE ratio in luminal contents (primarily nascent VLDLs) was 22% lower in female ( Figure  5C , PϽ0.05), and 26% lower in male ( Figure 5D , PϽ0.01), Pemt Ϫ/Ϫ /Ldlr Ϫ/Ϫ mice than in Pemt ϩ/ϩ /Ldlr Ϫ/Ϫ mice. These data indicate that elimination of PEMT reduces the PC/PE ratio of nascent VLDLs in the microsomal lumen. We also measured the PL composition of hepatic microsomes which might be expected to determine the PL composition of luminal VLDLs. Figure 5E shows that the level of microsomal PC was significantly lower in Pemt Ϫ/Ϫ /Ldlr Ϫ/Ϫ mice than in Pemt ϩ/ϩ /Ldlr Ϫ/Ϫ mice, so that the PC/PE ratio of microsomes was reduced by 40%, and of luminal contents by 26% ( Figure 5D ). These data indicate that even a small reduction in hepatic microsomal PC content (17% in males and 14% in females) significantly decreased the PC/PE molar ratio in nascent VLDLs.
Consistent with the gel filtration analyses ( Figure 1C and  1D) , the amount of PC in plasma VLDLs at steady state was significantly (PϽ0.05) lower in Pemt Ϫ/Ϫ /Ldlr Ϫ/Ϫ mice than in Pemt ϩ/ϩ /Ldlr Ϫ/Ϫ mice ( Figure 5F ). Notably, the amount of PC in plasma VLDLs was Ͼ20 fold higher than PE ( Figure  5F ). However, when plasma lipases were inhibited by Poloxamer 407, the PC/PE ratio was only Ϸ10 (Figure 5A ), indicating that PE in plasma VLDLs is preferentially de- graded relative to PC. The possibility that PE in preference to PC exchanges with other lipoproteins or cell membranes cannot be excluded.
We also observed a difference in average diameter of plasma VLDLs from mice of the 2 genotypes ( Figure 5G) 
Role of PEMT in VLDL Clearance from Plasma
To determine whether the altered PL composition of VLDLs modified VLDL metabolism in the circulation, we compared the rate of clearance of plasma VLDLs generated by Pemt mice is unlikely to be attributable to changes in the activity of these lipases.
Discussion
Our data provide clear evidence that elimination of PC biosynthesis via PEMT strikingly attenuates atherosclerosis by Ϸ80% in Ldlr Ϫ/Ϫ mice. This beneficial effect is likely attributable to reduction in plasma levels of atherogenic apoB-containing lipoproteins caused, at least in part, by altered PL composition of the particles.
Altered Phospholipid Composition of VLDLs
We propose that elimination of PEMT, and the impaired conversion of PE to PC, disturb hepatic PL homeostasis and reduce the PC/PE ratio of microsomes, the intracellular site of VLDL assembly, thereby reducing the PC/PE ratio of nascent VLDLs. Attenuation of hepatic PC biosynthesis via the CDP-choline pathway also changes the PL composition of nascent VLDLs and appears to induce post-ER degradation of the particles. 17 Our data are consistent with the idea that the abnormal PL composition of VLDLs secreted by PEMTdeficient hepatocytes/livers alters lipoprotein metabolism because PLs on the lipoprotein surface provide a site of contact with lipases, lipid transport proteins, and cell surface receptors. Nascent VLDLs from the ER, 16, 17 Golgi, 14 and VLDLs from plasma of rats in which lipases were inhibited 15 are enriched in PE compared to mature circulating VLDLs. Thus, during lipolysis of nascent VLDLs, PE appears to be hydrolyzed in plasma in preference to PC. Unique structural features of PE, 32 or reduced PC/PE ratio of the lipoprotein monolayer, might alter the conformation of exposed apolipoproteins, thereby increasing lipolysis of the particles or increasing binding to cell surface receptors.
The diameter of nascent VLDLs in plasma of Pemt Ϫ/Ϫ / Ldlr Ϫ/Ϫ mice was larger than in Pemt ϩ/ϩ /Ldlr Ϫ/Ϫ mice. This observation supports our previous observation that in rats fed a choline-deficient diet, in which the PC content of ER and Golgi was reduced, the diameter of plasma VLDLs was 16% larger than in rats supplemented with choline. 17, 33 
Mechanisms by Which PEMT Deficiency Decreases Plasma Atherogenic Lipoproteins
We attribute the Ϸ80% reduction in atherosclerotic lesions in Pemt Ϫ/Ϫ /Ldlr Ϫ/Ϫ mice primarily to decreased plasma levels of apoB-containing lipoproteins. Our experiments indicate that the underlying mechanism by which PEMT deficiency reduces the number of apoB-containing lipoprotein particles is mainly enhanced VLDL clearance combined with a relatively minor decrease in VLDL secretion.
Similar to our previous observations in Pemt Ϫ/Ϫ (Ldlr ϩ/ϩ ) mice, 8 we show that the hepatic secretion of TG and apoB was reduced by deletion of PEMT in Ldlr Ϫ/Ϫ mice, although the magnitude of the decrease was less than in mice expressing LDL receptors. 8 This observation, combined with altered PL composition of VLDLs, suggests that in the absence of PEMT newly-synthesized apoB-containing lipoproteins are incorrectly assembled and partially targeted for removal by a LDL receptor-dependent mechanism. 34 -37 Superimposed on the reduction in VLDL secretion, PEMT deficiency in Ldlr Ϫ/Ϫ mice increased the catabolism/removal of VLDLs from plasma. We propose that the decreased PC/PE ratio in VLDLs secreted by PEMT-deficient livers/hepatocytes is, at least partly, responsible for the more rapid catabolism of VLDLs generated by Pemt Ϫ/Ϫ /Ldlr Ϫ/Ϫ mice compared to VLDLs generated by Pemt ϩ/ϩ /Ldlr Ϫ/Ϫ mice. In addition to hydrolyzing VLDL-TG, both hepatic and LP lipases exhibit phospholipase activities, 38 and PE is preferred over PC as a substrate for hepatic lipase. 39 Nevertheless, the distinct PL compositions of the VLDLs produced by Pemt ϩ/ ϩ/Ldlr Ϫ/Ϫ mice and Pemt Ϫ/Ϫ /Ldlr Ϫ/Ϫ mice most likely cannot be explained by differences in activities of lipoprotein lipase or hepatic lipase 40 because the activity of neither lipase was altered by PEMT deficiency. The current data cannot exclude the possibility that an enhanced LDLR-independent hepatic reuptake of newly secreted apoB-containing lipoprotein particles, as well as of VLDL remnants, might also contribute to decreased plasma levels of apoB-containing lipoproteins in the PEMT-deficient mice.
Reduction in Atherosclerotic Lesions
The reduction in plasma cholesterol in Pemt Ϫ/Ϫ /Ldlr Ϫ/Ϫ mice is presumably the major reason for the reduced atherosclerosis. Our data suggest that an accelerated clearance of lipoproteins enriched in PE might be advantageous. When VLDL-TG is initially hydrolyzed, VLDL remnants are formed and are either removed by the liver or converted to IDLs and LDLs, two highly atherogenic lipoproteins that are enriched in cholesteryl esters. 41 Apparently, clearance of particles with reduced PC/PE ratio is preferred.
The reduction in atherosclerotic lesions also coincides with a decreased amount of plasma Hcy. The relationship between plasma Hcy and vascular physiology has been extensively studied (reviewed in 26 ). Moderate hyperhomocysteinemia (plasma Hcy Ͼ10 Ͻ100 mol/L) correlates with development of atherosclerosis, and an even smaller increase in plasma Hcy impairs vascular function. For example, in cystathionine ␤-synthase-deficient mice, a 4-to 5-mol/L increase in Hcy was associated with impaired endotheliumdependent vasodilation and increased oxidative stress, 42 processes that are linked to atherosclerosis. PEMT deficiency reduced plasma Hcy by 3 mol/L. Because Pemt Ϯ /Ldlr Ϫ/Ϫ
and Pemt Ϫ/Ϫ /Ldlr Ϫ/Ϫ mice have similar lipid profiles, we speculate that the reduction in Hcy contributes to decreased plaque formation in Pemt Ϫ/Ϫ /Ldlr Ϫ/Ϫ mice. In humans, a meta-analysis of large prospective studies concluded that a 3-mol/L increase in plasma Hcy increases the occurrence of myocardial infarction and stroke by 10% and 20%, respectively. Although recent Hcy-lowering programs did not show any protection against cardiovascular events, 43 the incidence of stroke was reduced. 44 
Conclusion
We propose that the decrease in PC in nascent VLDL particles determines their metabolic fate and reduces the amounts of atherogenic lipoproteins by decreasing VLDL secretion and increasing VLDL clearance from plasma. Consequently, we propose that the lower level of apoB-containing lipoproteins in Pemt Ϫ/Ϫ /Ldlr Ϫ/Ϫ mice compared to Pemt ϩ/ϩ / Ldlr Ϫ/Ϫ mice, possibly in concert with a lower level of plasma Hcy, attenuates atherosclerosis induced by a HF/HC diet.
